Search results
Showing 61 to 75 of 1516 results for patients and public
Glycopyrronium bromide cream for treating severe primary axillary hyperhidrosis [ID6487]
In development Reference number: GID-TA11628 Expected publication date: 11 March 2026
In development Reference number: GID-TA11221 Expected publication date: TBC
Resmetirom for treating non-alcoholic steatohepatitis and liver fibrosis [ID6529]
In development Reference number: GID-TA11414 Expected publication date: 10 June 2026
This quality standard covers promoting health and preventing premature mortality among black, Asian and other minority ethnic groups. It is relevant to all age groups and all settings.
View quality statements for QS167Show all sections
Sections for QS167
- Quality statements
- Quality statement 1: Designing health and wellbeing programmes
- Quality statement 2: Peer and lay roles
- Quality statement 3: Referring people at high risk of type 2 diabetes
- Quality statement 4: Cardiac rehabilitation
- Quality statement 5: Support for people with mental health problems
- Quality statement 6: Physical health checks for people with serious mental illness
- Update information
In development Reference number: GID-TA11817 Expected publication date: 09 July 2026
In development Reference number: GID-TA11554 Expected publication date: TBC
In development Reference number: GID-TA11220 Expected publication date: TBC
Leadless cardiac pacemaker implantation for bradyarrhythmias
In development Reference number: GID-IPG10340 Expected publication date: 25 February 2026
In development Reference number: GID-HST10067 Expected publication date: 19 August 2026
In development Reference number: GID-TA11502 Expected publication date: 02 December 2026
This guideline covers the prevention and management of overweight, obesity and central adiposity in children, young people and adults. It brings together and updates all NICE's previous guidelines on overweight and obesity. It does not cover pregnancy.
Show all sections
Sections for NG246
In development Reference number: GID-TA11477 Expected publication date: 12 August 2026
Larotrectinib for treating NTRK fusion-positive advanced solid tumours (MA review of TA630) [ID6292]
Awaiting development Reference number: GID-TA11565 Expected publication date: 21 May 2026
In development Reference number: GID-TA11768 Expected publication date: 03 September 2026
In development Reference number: GID-TA11576 Expected publication date: 18 June 2026